https://doi.org/10.4081/reumatismo.2024.1638
Disease activity assessment for juvenile idiopathic arthritis in transitional care
Submitted: 22 August 2023
Accepted: 24 March 2024
Published: 24 June 2024
Accepted: 24 March 2024
Abstract Views: 1403
PDF: 376
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Objective. The indices to measure disease activity of chronic arthritis in adulthood and childhood are different. Therefore, assessing the status of the disease in young patients with juvenile idiopathic arthritis (JIA) can be tricky, especially when the transition to adult care is ongoing. The aim of our study was to assess the level of correlation between adult and juvenile scores in the measurement of disease activity in JIA patients during transitional care.
Methods. We estimated the disease activity by using the Juvenile Arthritis Disease Activity Score 71 (JADAS71), clinical JADAS, adult Disease Activity Score (DAS28), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index (CDAI) in JIA patients in transitional care. We enrolled patients older than 16 years at the time of the first transition visit, and disease activity was assessed at baseline and 12 months. Regression analyses were carried out to estimate the level of agreement among the different indices.
Results. We recruited 26 patients with JIA; 11 patients were polyarticular (42.3%) and 15 patients were oligoarticular (53.1%). The mean age at diagnosis was 7.7±3.9 years and the age at the first evaluation was 20.9±3.7 years. The correlation between JADAS71 and DAS28 was r2=0.69, r2=0.86 between JADAS71 and SDAI, and r2=0.81 between JADAS71 and CDAI.
Conclusions. SDAI and JADAS71 showed the best correlation, but a few patients were not captured at the same level of disease activity. New prospective studies with a larger number of patients will be needed in this field.
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369: 767-78.
DOI: https://doi.org/10.1016/S0140-6736(07)60363-8
Consolaro A, Giancane G, Schiappapietra B, Davì S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2016; 14: 23.
DOI: https://doi.org/10.1186/s12969-016-0085-5
Stringer E, Scott R, Mosher D, MacNeill I, Huber AM, Ramsey S, et al. Evaluation of a Rheumatology Transition Clinic. Pediatr Rheumatol Online J 2015; 13: 22.
DOI: https://doi.org/10.1186/s12969-015-0016-x
van Pelt PA, Kruize AA, Goren SS, van der Net J, Uiterwaal C, Kuis W, et al. Transition of rheumatologic care, from teenager to adult: which health assessment questionnaire can be best used? Clin Exp Rheumatol 2010; 28: 281-6.
Conti F, Pontikaki I, D’Andrea M, Ravelli A, De Benedetti F. Patients with juvenile idiopathic arthritis become adults: the role of transitional care. Clin Exp Rheumatol 2018; 36: 1086-94.
Ravelli A, Sinigaglia L, Cimaz R, Alessio M, Breda L, Cattalini M, et al. Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey. Clin Exp Rheumatol 2019; 37: 1084-91.
van Pelt PA, Dolhain RJEM, Kruize AA, Ammerlaan JJW, Hazes JW, Bijlsma JWJ, et al. Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study. Clin Exp Rheumatol 2018; 36: 163-8.
Hersh AO, Pang S, Curran ML, Milojevic DS, Von Scheven E. The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center. Pediatr Rheumatol Online J 2009; 7: 13.
DOI: https://doi.org/10.1186/1546-0096-7-13
Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 658-66.
DOI: https://doi.org/10.1002/art.24516
Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244-57.
DOI: https://doi.org/10.1093/rheumatology/keg072
Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796-806.
DOI: https://doi.org/10.1186/ar1740
Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, et al. Remission, minimal disease activity and acceptable symptom state in juvenile idiopathic arthritis. Arthritis Rheum 2012; 64: 2366-74.
DOI: https://doi.org/10.1002/art.34373
Consolaro A, Ruperto N, Bracciolini G, Frisina A, Gallo MC, Pistorio A, et al. Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. Ann Rheum Dis 2014; 73: 1380-3.
DOI: https://doi.org/10.1136/annrheumdis-2013-204186
Wu Q, Chaplin H, Ambrose N, Sen D, Leandro MJ, Wing C, et al. Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis. Ann Rheum Dis 2016; 75: 635-6.
DOI: https://doi.org/10.1136/annrheumdis-2015-208462
How to Cite
La Torre, F., Coppola, C., Anelli, M., Cacciapaglia, F., Lopalco, G., Cardinale, F., & Iannone, F. (2024). Disease activity assessment for juvenile idiopathic arthritis in transitional care. Reumatismo, 76(2). https://doi.org/10.4081/reumatismo.2024.1638
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- G. De Rosa, C. Mignogna, THE HISTOPATHOLOGY OF PSORIASIS , Reumatismo: Vol. 59 No. s1 (2007)
- A. Gava, A. Furlan, F. Navaglia, M. Miorin, M. Razetti, D. Basso, M. Plebani, L. Punzi, Utility of denaturing high performance liquid chromatography (DHPLC) for the diagnosis of mevalonate kinase deficiency in periodic fevers of autoinflammatory nature suspicion , Reumatismo: Vol. 61 No. 3 (2009)
- N. Ughi, G.D. Sebastiani, R. Gerli, C. Salvarani, S. Parisi, A. Ariani, I. Prevete, M. Manara, F. Rumi, C.A. Sciré, A. Bortoluzzi, The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica , Reumatismo: Vol. 72 No. 1 (2020)
- F. Bellisai, G. Morozzi, M.R. Bacarelli, A. Radice, R.A. Sinico, J. Wieslander, G.D. Sebastiani, V. Campanella, R. Marcolongo, M. Galeazzi, Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? , Reumatismo: Vol. 53 No. 1 (2001)
- E. Favalli, F. Ingegnoli, S. Zeni, M. Faré, F. Fantini, HLA typing in systemic sclerosis , Reumatismo: Vol. 53 No. 3 (2001)
- G. Porciello, R. Scarpato, F. Storino, F. Cagetti, R. Marcolongo, L. Migliore, C. Ferri, M. Galeazzi, The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results , Reumatismo: Vol. 54 No. 1 (2002)
- L. Fioravante da Silveira, A. Zago, D. Zanchet, D. Chemello, Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report , Reumatismo: Vol. 75 No. 2 (2023)
- M. Ponteggia, L. Di Cato, F. Ponteggia, M. Pica, A. Puxeddu, S. Coaccioli, Evaluation of the peak bone mass by quantitative heel ultrasound in young women of the centre of Italy , Reumatismo: Vol. 55 No. 1 (2003)
- C.U. Manzini, V. Spina, M.T. Mascia, R. Magistro, G. Carpenito, C. Ferri, Diffuse post-traumatic calcification of the anterior longitudinal ligamentum of cervical and dorsal spine , Reumatismo: Vol. 56 No. 2 (2004)
- A. Migliore, S. Tormenta, F. Iannesi, E. Mascheroni, E. Barbati, A. Capuano, M. Diaco, U. Massafra, C. Padalino, F. Vacca, A. Alimonti, L.S. Martin, M. Granata, Correlation between radiologic and ultrasonographic patterns and clinical manifestations in symptomatic hip osteoarthritis , Reumatismo: Vol. 59 No. 1 (2007)
<< < 52 53 54 55 56 57 58 59 60 61 > >>
You may also start an advanced similarity search for this article.
